Forget Ozempic: This High?Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Source: Motley Fool
2026-02-20 13:35:00 ET
Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's Ozempic has reignited competition between theses two fierce rivals.
Meanwhile, another major presence in the medical world -- device maker Intuitive Surgical (NASDAQ: ISRG) -- continues to chug along. And it looks set to do so regardless of which drug company wins the GLP-1 race.
Here's why you might want to add Intuitive Surgical shares to your investment portfolio.
Intuitive Surgical Inc.
NASDAQ: ISRG
ISRG Trading
-0.04% G/L:
$488.49 Last:
578,419 Volume:
$489.23 Open:
ISRG Latest News
February 26, 2026 09:25:00 am
Got $10,000? This Under?the?Radar Medical Device Giant Could Be a Millionaire Maker by 2036.
ISRG Stock Data
$176,066,468,900
352,644,325
0.01%
1322
N/A
Medical Equipment & Supplies
Healthcare
US
Sunnyvale
